Katherine Rivera-Spoljaric, M.D., MSCI  rivera_k@wustl.edu

Profile picture
Associate Professor of Pediatrics, Division of Pediatric Allergy, Immunology, and Pulmonary Medicine
Medical Director, Multidisciplinary Technology Dependent Child Center, Division of Allergy, Immunology, and Pulmonary Medicine
Co-Director, Severe Asthma Clinic for Kids (SACK), Divison of Allergy, Immunology, and Pulmonary Medicine
Allergy and Pulmonary Medicine

phone: (314) 454-2694

Clinical Interests

Dr. Rivera-Spoljaric is a member of the Division of Allergy, Immunology and Pulmonary Medicine. She is the Medical Director of the Multidisciplinary Technology Dependent Child Clinic and also provides consultative services at Ranken Jordan Pediatric Specialty Hospital. She received her undergraduate degree in general sciences from the University of Puerto Rico, San Juan, PR. She received her medical degree from Ponce School of Medicine, Ponce, PR. She completed a residency in Pediatrics at Miami Children's Hospital and her Pulmonology fellowship at St Louis Children's Hospital, Washington University School of Medicine, St Louis, MO. She joined the faculty of Washington University in 2007. She is board certified in Pediatrics. She is a member of several organizations including the American Thoracic Society. Dr. Rivera’s research interests include childhood asthma and technology dependent children. She is involved with research efforts through the Childhood Asthma Research and Education (CARE) network and AsthmaNet, both multi-centered networks examining therapeutic approaches to childhood asthma.


  • BS, University of Puerto Rico1997
  • MD, Ponce School of Medicine2001
  • MSCI, Washington University School of Medicine2008


  • Resident, Miami Children's Hospital2001 - 2004
  • Fellow, Washington University School of Medicine2004 - 2007
  • Advanced Training in Motivational Interviewing, Berg-Smith Training and Consulting2011
  • Research Intensive in Comparative Effectiveness, Oregan Health and Schience University2011
  • Pediatric Leadership Development Skills Training, Washington University School of Medicine, Department of Pediatrics2015 - 2015
  • Diversity Advisor , Washington University School of Medicine2020 - 2020

Licensure and Board Certification

  • 2004 - PresMO, Medical License
  • 2006 - PresAmerican Board of Pediatrics, General Pediatrics
  • 2012 - PresAmerican Board of Pediatrics, Pediatric Pulmonology

Honors and Awards

  • Honor Roll and Dean's list, University of Puerto Rico - Rio Piedras1993 - 1997
  • Summer Research Grant, Award by Minority Biomedical Research Support1998
  • Academic Honors in Epidemiology, Biostatistics, Family Medicine, Psychiatry, Obstetrics and Gynecology, and Radiology1998 - 2000
  • Clinical Distinction Award, Ponce School of Medicine2001
  • Nominated, Human in Medical Award, Ponce School of Medicine2001
  • K30 Award for Mentored Training Program in Clinical Investigation2006
  • American Thoracic Society Minority Trainee Travel Award2007
  • Faculty Diversity Scholar for Washington University School of Medicine2007 - 2010
  • KM1 Scholar for Comparative Effectiveness Research2011 - 2013
  • American Lung Association Clinical Patient Care Research Grant Award2013 - 2015
  • Clinical Research Award, Asian Pacific Society of Respirology2014
  • Hill Day 2017, Advocate for Lung Health, American Thoracic Society, Washington, D.C.2017

Recent Publications view all (24)

Publication Co-Authors

  1. A child with chronic cough and eosinophilia secondary to Strongyloides stercoralis infection. Pediatr Pulmonol. 2022;57(10):2562-2564. PMID:35778783 
  2. Airway multidrug-resistant organisms in a population of tracheostomy and chronic ventilator-dependent children at a tertiary care pediatric hospital. Pediatr Pulmonol. 2022. PMID:36100968 
  3. Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet. 2022;400(10351):502-511. PMID:35964610 
  4. Childhood Asthma Incidence, Early and Persistent Wheeze, and Neighborhood Socioeconomic Factors in the ECHO/CREW Consortium. JAMA Pediatr. 2022;176(8):759-767. PMCID:PMC9127710  PMID:35604671 
  5. Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study. J Allergy Clin Immunol. 2022;150(2):302-311. PMCID:PMC9155183  PMID:35660376 
  6. Sociodemographic Variation in Children's Health Behaviors During the COVID-19 Pandemic. Child Obes. 2022. PMID:35856858 
  7. Human Epidemiology and RespOnse to SARS-CoV-2 (HEROS): Objectives, Design and Enrollment Results of a 12-City Remote Observational Surveillance Study of Households with Children using Direct-to-Participant Methods. medRxiv. 2022. PMCID:PMC9298141  PMID:35860216 
  8. The Role of Childhood Asthma in Obesity Development: A Nationwide US Multicohort Study. Epidemiology. 2022;33(1):131-140. PMCID:PMC8633057  PMID:34561347 
  9. Trajectories of adiposity indicators and association with asthma and lung function in urban minority children. J Allergy Clin Immunol. 2021;148(5):1219-1226.e7. PMCID:PMC8578316  PMID:34166677 
  10. Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation. Contemp Clin Trials. 2021;100:106228. PMCID:PMC7887056  PMID:33242697 
  11. Challenges in assessing the efficacy of systemic corticosteroids for severe wheezing episodes in preschool children. J Allergy Clin Immunol. 2019;143(5):1934-1937.e4. PMCID:PMC6504562  PMID:30660645 
  12. Glutathione and arginine levels: Predictors for acetaminophen-associated asthma exacerbation? J Allergy Clin Immunol. 2018;142(1):308-311.e9. PMCID:PMC6035773  PMID:29518418 
  13. Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations. N Engl J Med. 2018;378(10):891-901. PMCID:PMC5972517  PMID:29504498 
  14. Acetaminophen versus Ibuprofen in Young Children with Mild Persistent Asthma. N Engl J Med. 2016;375(7):619-30. PMCID:PMC5085065  PMID:27532828 
  15. An Official American Thoracic Society Clinical Practice Guideline: Pediatric Chronic Home Invasive Ventilation. Am J Respir Crit Care Med. 2016;193(8):e16-35. doi:10.1164/rccm.201602-0276ST  PMID:27082538 
  16. Shared clinician-patient decision-making about treatment of pediatric asthma: what do we know and how can we use it? Curr Opin Allergy Clin Immunol. 2014;14(2):161-7. PMID:24553296 
  17. Heterozygous 24-polyalanine repeats in the PHOX2B gene with different manifestations across three generations. Pediatr Pulmonol. 2014;49(2):E13-E16. doi:10.1002/ppul.22731  PMID:23460419 
  18. Do oral corticosteroids reduce the severity of acute lower respiratory tract illnesses in preschool children with recurrent wheezing? J Allergy Clin Immunol. 2013;131:1518-1525. doi:10.1016/j.jaci.2013.01.034  PMID:23498594 
  19. Nonrespiratory symptoms before loss of asthma control in children. J Allergy Clin Immunol Pract. 2013;1(3):304-6.e1-2. doi:10.1016/j.jaip.2013.01.012  PMID:24565492 
  20. Recurrent pleural effusion without intrathoracic migration of ventriculoperitoneal shunt catheter: a case report. Pediatr Pulmonol. 2012;47(1):91-5. doi:10.1002/ppul.21510  PMID:22170808 
  21. Caregivers report a wide variety of early signs and symptoms of impending asthma exacerbations that are not different between preschool and school-aged children. J Allergy Clin Immunol. 2011;128(5):1109-11.e1-5. doi:10.1016/j.jaci.2011.06.033  PMID:21906791 
  22. Detection and home management of worsening asthma symptoms. Ann Allergy Asthma Immunol. 2009;103(6):469-73. doi:10.1016/S1081-1206(10)60262-1  PMID:20084839 
  23. Signs and symptoms that precede wheezing in children with a pattern of moderate-to-severe intermittent wheezing. J Pediatr. 2009;154(6):877-81.e4. doi:10.1016/j.jpeds.2008.12.029  PMCID:PMC3086348  PMID:19324370 
  24. Fibrosis quística: ¿Cuándo referir un niño para trasplante pulmonar? Neumología Pediátrica. 2007;2:84-89. 
Last updated: 10/06/2022
© 2022 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130